GoldStone Resources Ltd (GRL):企業の財務・戦略的SWOT分析

◆英語タイトル:GoldStone Resources Ltd (GRL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDNE17777FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Nuclear Energy
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GoldStone Resources Ltd (GoldStone) is a mining and mineral exploration company. The company acquires, explores, develops and produces gold properties. It offers exploration projects such as Homase-Akrokeri permits, Manso Amenfi permits, Sangola permits, Oyem permits and Ngoutou permits, among others. GoldStone’s Homase-Akrokeri project is located near AngloGold Ashanti’s Obuasi mine within the mineralized Ashanti Gold Belt in Ghana. The company’s Manso Amenfi permit is located at south-west of the Homase permit. It has operations throughout the UK, Ghana, Senegal and Gabon. GoldStone is headquartered in Jersey, the UK

GoldStone Resources Ltd Key Recent Developments

Feb 22,2021: GoldStone Resources secures all permits for Homase South Pit in Ghana
Feb 19,2021: GoldStone Resources appoints SP Angel Corporate Finance as broker
Feb 15,2021: GoldStone obtains environmental permit for Homase South Pit in Ghana
Dec 03,2020: GoldStone Resources announces approval of expanded mining lease and update on re Homase South
Jul 17,2020: Goldstone Resources: Extended resource drilling and updated DEP

This comprehensive SWOT profile of GoldStone Resources Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of GoldStone Resources Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

GoldStone Resources Ltd – Key Information
GoldStone Resources Ltd – Overview
GoldStone Resources Ltd – Key Employees
GoldStone Resources Ltd – Key Employee Biographies
GoldStone Resources Ltd – Key Operational Heads
GoldStone Resources Ltd – Major Products and Services
GoldStone Resources Ltd – History
GoldStone Resources Ltd – Company Statement
GoldStone Resources Ltd – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

GoldStone Resources Ltd – Business Description
GoldStone Resources Ltd – Corporate Strategy
GoldStone Resources Ltd – SWOT Analysis
SWOT Analysis – Overview
GoldStone Resources Ltd – Strengths
GoldStone Resources Ltd – Weaknesses
GoldStone Resources Ltd – Opportunities
GoldStone Resources Ltd – Threats
GoldStone Resources Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

GoldStone Resources Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

GoldStone Resources Ltd, Key Information
GoldStone Resources Ltd, Key Ratios
GoldStone Resources Ltd, Share Data
GoldStone Resources Ltd, Major Products and Services
GoldStone Resources Ltd, History
GoldStone Resources Ltd, Key Employees
GoldStone Resources Ltd, Key Employee Biographies
GoldStone Resources Ltd, Key Operational Heads
GoldStone Resources Ltd, Other Locations
GoldStone Resources Ltd, Subsidiaries

GoldStone Resources Ltd, Key Competitors
GoldStone Resources Ltd, SWOT Analysis
GoldStone Resources Ltd, Ratios based on current share price
GoldStone Resources Ltd, Annual Ratios
GoldStone Resources Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[GoldStone Resources Ltd (GRL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Sonoma Pharmaceuticals Inc (SNOA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Mediobanca – Banca di Credito Finanziario SpA (MB):企業の財務・戦略的SWOT分析
    Mediobanca - Banca di Credito Finanziario SpA (MB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Premier Foods plc:企業の戦略・SWOT・財務情報
    Premier Foods plc - Strategy, SWOT and Corporate Finance Report Summary Premier Foods plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CASIO COMPUTER CO., LTD.:企業の戦略・SWOT・財務情報
    CASIO COMPUTER CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary CASIO COMPUTER CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Zenotech Laboratories Ltd (532039):製薬・医療:M&Aディール及び事業提携情報
    Summary Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company’s Generic biopharmaceuticals is further sub-divided into generic biological an …
  • Abiomed Inc (ABMD):医療機器:M&Aディール及び事業提携情報
    Summary Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for cir …
  • Bionomics Ltd (BNO):企業の財務・戦略的SWOT分析
    Summary Bionomics Ltd (Bionomics) is a biopharmaceutical company that discovers and develops treatments for cancer, and central nervous system disorders such as anxiety, depression and Alzheimer's disease. The company provides pipeline products such as BNC210, BNC 105, BNC101 and BNC375, among other …
  • Monex Group, Inc.:企業の戦略・SWOT・財務情報
    Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monex Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Neue Bank AG:企業の戦略・SWOT・財務情報
    Neue Bank AG - Strategy, SWOT and Corporate Finance Report Summary Neue Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kasbah Resources Limited:戦略・SWOT・企業財務分析
    Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Kasbah Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MorphoSys AG (MOR)-製薬・医療分野:企業M&A・提携分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product include MOR208, MOR202, MOR103, MOR209/ES414, MOR106, and MOR107, among others. It drugs are used in the treatment of different types of canc …
  • Millennium Minerals Limited:企業の戦略・SWOT・財務情報
    Millennium Minerals Limited - Strategy, SWOT and Corporate Finance Report Summary Millennium Minerals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CA Technologies, Inc.:企業の戦略・SWOT・財務情報
    CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • C-Rad AB (CRAD B)-医療機器分野:企業M&A・提携分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • Adocia SAS (ADOC):企業の財務・戦略的SWOT分析
    Summary Adocia SAS (Adocia) is a biotechnology comapny involved in the develoment of therapeutic proteins. The company provides products such as formulation of PDGF-BB for the treatment of diabetic foot ulcers. Adocia's novel insulin formulations is used for the treatment of diabetes and BioChaperon …
  • ImmunoCellular Therapeutics Ltd (IMUC):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Mitsui-Soko Holdings Co Ltd (9302):企業の財務・戦略的SWOT分析
    Mitsui-Soko Holdings Co Ltd (9302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆